Hydroxyurea dermopathy

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Hydroxyurea dermopathy
Chemical structure of Hydroxyurea
Synonyms	Hydroxyurea-induced dermopathy
Pronounce	N/A
Specialty	Dermatology
Symptoms	Skin ulcer, hyperpigmentation, nail changes
Complications	Infection, scarring
Onset	Variable, often after prolonged use of hydroxyurea
Duration	Chronic, may persist with continued use of the drug
Types	N/A
Causes	Hydroxyurea use
Risks	Long-term use of hydroxyurea, higher doses
Diagnosis	Clinical evaluation, history of hydroxyurea use
Differential diagnosis	Vasculitis, pyoderma gangrenosum, necrobiosis lipoidica
Prevention	Dose adjustment, alternative medications
Treatment	Discontinuation or reduction of hydroxyurea, topical corticosteroids, wound care
Medication	N/A
Prognosis	Variable, may improve with cessation of hydroxyurea
Frequency	Rare
Deaths	N/A

Hydroxyurea dermopathy is a cutaneous condition that arises as a side effect of the medication hydroxyurea, which is commonly used in the treatment of certain hematological disorders and cancers. This condition is characterized by specific changes in the skin, particularly affecting the lower extremities.

Clinical Features

Hydroxyurea dermopathy typically presents with a range of skin changes. The most common manifestations include:

• Hyperpigmentation: Patients may develop darkened patches of skin, particularly on the legs and feet.
• Atrophy: The skin may become thin and fragile, leading to an increased risk of ulceration.
• Scaling: Affected areas may exhibit dry, scaly patches.
• Nail Changes: Some patients experience changes in their nails, such as onycholysis or nail dystrophy.

Pathophysiology

The exact mechanism by which hydroxyurea causes these skin changes is not fully understood. However, it is believed to be related to the drug's effects on DNA synthesis and repair, as well as its impact on keratinocyte function. Hydroxyurea interferes with the normal proliferation of skin cells, leading to the observed dermatological effects.

Diagnosis

Diagnosis of hydroxyurea dermopathy is primarily clinical, based on the characteristic appearance of the skin changes and the patient's history of hydroxyurea use. A biopsy may be performed to rule out other conditions and to confirm the diagnosis by demonstrating specific histological features such as epidermal atrophy and pigmentary incontinence.

Management

Management of hydroxyurea dermopathy involves several strategies:

• Discontinuation or Dose Adjustment: Reducing the dose of hydroxyurea or discontinuing the drug may lead to improvement in skin symptoms.
• Topical Treatments: Emollients and topical corticosteroids may be used to alleviate symptoms such as dryness and scaling.
• Monitoring: Regular dermatological assessments are recommended for patients on long-term hydroxyurea therapy to monitor for skin changes.

Prognosis

The prognosis for patients with hydroxyurea dermopathy is generally good, especially if the condition is recognized early and managed appropriately. Skin changes may improve with dose adjustment or discontinuation of the drug, although some changes, such as hyperpigmentation, may persist.

See also

• Hydroxyurea
• Cutaneous side effects of drugs
• Hematological disorders
• Skin pigmentation